Financial News
Latest News about EDIT
Recent news which mentions EDIT
Precigen's Overnight Cell Manufacturing Technology Could Offer Advanced AML Patients The Option Of Promising CAR-T Therapy
December 08, 2022
From Benzinga
2 Beaten-Down Stocks to Watch Closely Next Year
December 06, 2022
From Motley Fool
Editas Medicine Touts Positive Safety, Efficacy Data From Two Sickle Cell Disease Patients
December 06, 2022
Tickers
EDIT
From Benzinga
Why Shares of Editas Medicine Dropped 15.5% in November
December 05, 2022
Tickers
EDIT
From Motley Fool
Where Will Editas Medicine Be in 1 Year?
November 20, 2022
From Motley Fool
Gene Editing Stock's Prospects Cut In Half By Analyst, Citing Limited Value In Retina Treatment
November 18, 2022
Tickers
EDIT
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 18, 2022
November 18, 2022
From Benzinga
Palo Alto To Surge Around 38%? Plus This Analyst Predicts $65 For Helmerich & Payne
November 18, 2022
From Benzinga
Intuit To $490? Here Are 5 Other Price Target Changes For Friday
November 18, 2022
From Benzinga
From Benzinga
Why Inotiv Shares Dipped 57%; Here Are 76 Biggest Movers From Yesterday
November 18, 2022
From Benzinga
Nasdaq Down 60 Points; Alibaba Posts Upbeat Q2 Earnings
November 17, 2022
From Benzinga
Why Elevate Credit Shares Are Trading Higher By Over 71%? Here Are 43 Stocks Moving In Thursday's Mid-Day Session
November 17, 2022
From Benzinga
Citing Small Population, Editas Medicine Pauses Work On Gene Therapy Trial For Genetic Eye Disorder
November 17, 2022
Tickers
EDIT
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
November 17, 2022
From Benzinga
S&P 500 Down 1%; Crude Oil Drops Sharply
November 17, 2022
From Benzinga
BrightView Holdings, America's Car-Mart And Some Other Big Stocks Moving Lower On Thursday
November 17, 2022
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
November 17, 2022
From Benzinga
What 5 Analyst Ratings Have To Say About Editas Medicine
November 03, 2022
Tickers
EDIT
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 29, 2022
September 29, 2022
From Benzinga
From Benzinga
Down 35% This Year, Is This Small-Cap Stock a Buy?
July 21, 2022
From Motley Fool
The 3 Leaders of the Gene Editing Revolution
July 08, 2022
From InvestorPlace
7 Moonshot Investments Upending a $10 Trillion Industry
July 08, 2022
From InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
